Page 115 - Read Online
P. 115

Page 10 of 12                      Schofield et al. J Cancer Metastasis Treat 2020;6:10  I  http://dx.doi.org/10.20517/2394-4722.2019.43

                   2018;9:11489-502.
               8.   Ludvigsen M, Bjerregard Pedersen M, Lystlund Lauridsen K, Svenstrup Poulsen T, Hamilton-Dutoit SJ, et al. Proteomic profiling
                   identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Blood Adv 2018;2:2533-42.
               9.   Cancemi P, Buttacavoli M, Roz E, Feo S. Expression of alpha-enolase (ENO1), myc promoter-binding protein-1 (MBP-1) and matrix
                   metalloproteinases (MMP-2 and MMP-9) reflect the nature and aggressiveness of breast tumors. Int J Mol Sci 2019;20.
               10.  Tu SH, Chang CC, Chen CS, Tam KW, Wang YJ, et al. Increased expression of enolase alpha in human breast cancer confers tamoxifen
                   resistance in human breast cancer cells. Breast Cancer Res Treat 2010;121:539-53.
               11.  Zhan P, Zhao S, Yan H, Yin C, Xiao Y, et al. alpha-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway
                   in colorectal cancer. Mol Carcinog 2017;56:1427-37.
               12.  Zhao M, Fang W, Wang Y, Guo S, Shu L, et al. Enolase-1 is a therapeutic target in endometrial carcinoma. Oncotarget 2015;6:15610-27.
               13.  Qiao H, Wang Y, Zhu B, Jiang L, Yuan W, et al. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor
                   survival. J Cell Biochem 2019;120:18714-23.
               14.  Zhou X, Yao K, Zhang L, Zhang Y, Han Y, et al. Identification of differentiation-related proteins in gastric adenocarcinoma tissues by
                   proteomics. Technol Cancer Res Treat 2016;15:697-706.
               15.  Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation
                   partly via chemokine CCL20 induction. Eur J Cancer 2010;46:1712-23.
               16.  Zhu W, Li H, Yu Y, Chen J, Chen X, et al. Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma
                   patients. Cancer Manag Res 2018;10:5735-45.
               17.  Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, et al. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell
                   lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol 2015;8:22.
               18.  Racz A, Brass N, Hofer M, Sybrecht GW, Remberger K, et al. Gene amplification at chromosome 1pter-p33 including the genes PAX7
                   and ENO1 in squamous cell lung carcinoma. Int J Oncol 2000;17:67-73.
               19.  Cruz IN, Coley HM, Kramer HB, Madhuri TK, Safuwan NA, et al. Proteomics analysis of ovarian cancer cell lines and tissues reveals
                   drug resistance-associated proteins. Cancer Genomics Proteomics 2017;14:35-51.
               20.  Yin H, Wang L, Liu HL. ENO1 overexpression in pancreatic cancer patients and its clinical and diagnostic significance. Gastroenterol
                   Res Pract 2018;2018:3842198.
               21.  Sun L, Guo C, Cao J, Burnett J, Yang Z, et al. Over-expression of alpha-enolase as a prognostic biomarker in patients with pancreatic
                   cancer. Int J Med Sci 2017;14:655-61.
               22.  Cappello P, Tomaino B, Chiarle R, Ceruti P, Novarino A, et al. An integrated humoral and cellular response is elicited in pancreatic cancer
                   by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 2009;125:639-48.
               23.  Marangos PJ, Parma AM, Goodwin FK. Functional properties of neuronal and glial isoenzymes of brain enolase. J Neurochem
                   1978;31:727-32.
               24.  Kang HJ, Jung SK, Kim SJ, Chung SJ. Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr
                   D Biol Crystallogr 2008;64:651-7.
               25.  Brewer JM. Yeast enolase: mechanism of activation by metal ions. CRC Crit Rev Biochem 1981;11:209-54.
               26.  Petrak J, Ivanek R, Toman O, Cmejla R, Cmejlova J, et al. Deja vu in proteomics. A hit parade of repeatedly identified differentially
                   expressed proteins. Proteomics 2008;8:1744-9.
               27.  Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, et al. Proteomic identification of oxidatively modified proteins
                   in Alzheimer’s disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem
                   2002;82:1524-32.
               28.  Owen JB, Di Domenico F, Sultana R, Perluigi M, Cini C, et al. Proteomics-determined differences in the concanavalin-A-fractionated
                   proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer’s disease and mild cognitive impairment: implications
                   for progression of AD. J Proteome Res 2009;8:471-82.
               29.  Butterfield DA, Lange ML. Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism. J
                   Neurochem 2009;111:915-33.
               30.  Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in
                   rheumatoid arthritis. Arthritis Res Ther 2005;7:R1421-9.
               31.  Montes A, Dieguez-Gonzalez R, Perez-Pampin E, Calaza M, Mera-Varela A, et al. Particular association of clinical and genetic features
                   with autoimmunity to citrullinated alpha-enolase in rheumatoid arthritis. Arthritis Rheum 2011;63:654-61.
               32.  Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013;12:340-54.
               33.  Terrier B, Tamby MC, Camoin L, Guilpain P, Berezne A, et al. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-
                   enolase and are associated with interstitial lung disease. Ann Rheum Dis 2010;69:428-33.
               34.  Bergmann S, Schoenen H, Hammerschmidt S. The interaction between bacterial enolase and plasminogen promotes adherence of
                   Streptococcus pneumoniae to epithelial and endothelial cells. Int J Med Microbiol 2013;303:452-62.
               35.  Funk J, Schaarschmidt B, Slesiona S, Hallstrom T, Horn U, et al. The glycolytic enzyme enolase represents a plasminogen-binding
                   protein on the surface of a wide variety of medically important fungal species. Int J Med Microbiol 2016;306:59-68.
               36.  Li M, Li J, Wang J, Li Y, Yang P. Serum level of anti-alpha-enolase antibody in untreated systemic lupus erythematosus patients correlates
                   with 24-hour urine protein and D-dimer. Lupus 2018;27:139-42.
               37.  Peng B, Huang X, Nakayasu ES, Petersen JR, Qiu S, et al. Using immunoproteomics to identify alpha-enolase as an autoantigen in liver
                   fibrosis. J Proteome Res 2013;12:1789-96.
   110   111   112   113   114   115   116   117   118   119   120